Literature DB >> 20477259

MICs, MPCs and PK/PDs: a match (sometimes) made in hosts.

Christine K Hesje, Glenn S Tillotson, Joseph M Blondeau.   

Abstract

Year:  2007        PMID： 20477259     DOI： 10.1586/17476348.1.1.7

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN： 1747-6348            Impact factor:   3.772


× No keyword cloud information.
  8 in total

1.  Mutant prevention concentration (MPC) of ciprofloxacin against Salmonella enterica of epidemic and poultry origin.

Authors:  Rafaela Ferrari; Marciane Magnani; Roberta Barreiros Souza; Maria Cristina Bronharo Tognim; Tereza Cristina Rocha Moreira Oliveira
Journal:  Curr Microbiol       Date:  2010-09-25       Impact factor: 2.188

Review 2.  Individualising Therapy to Minimize Bacterial Multidrug Resistance.

Authors:  A J Heffernan; F B Sime; J Lipman; J A Roberts
Journal:  Drugs       Date:  2018-04       Impact factor: 9.546

3.  Minimal inhibitory and mutant prevention concentrations of azithromycin, clarithromycin and erythromycin for clinical isolates of Streptococcus pneumoniae.

Authors:  Kelli Metzler; Karl Drlica; Joseph M Blondeau
Journal:  J Antimicrob Chemother       Date:  2012-11-20       Impact factor: 5.790

4.  Mutant prevention concentrations of four carbapenems against gram-negative rods.

Authors:  Kim Credito; Klaudia Kosowska-Shick; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2010-03-22       Impact factor: 5.191

5.  Bacteriophage therapy and the mutant selection window.

Authors:  Benjamin J Cairns; Robert J H Payne
Journal:  Antimicrob Agents Chemother       Date:  2008-10-06       Impact factor: 5.191

6.  Comparing the minimum inhibitory and mutant prevention concentrations of selected antibiotics against animal isolates of Pasteurella multocida and Salmonella typhimurium.

Authors:  Jeanette M Wentzel; Louise J Biggs; Moritz Van Vuuren
Journal:  Onderstepoort J Vet Res       Date:  2022-01-10       Impact factor: 1.792

Review 7.  Establishing Antimicrobial Susceptibility Testing Methods and Clinical Breakpoints for Inhaled Antibiotic Therapy.

Authors:  Miquel B Ekkelenkamp; María Díez-Aguilar; Michael M Tunney; J Stuart Elborn; Ad C Fluit; Rafael Cantón
Journal:  Open Forum Infect Dis       Date:  2022-02-14       Impact factor: 3.835

8.  Spectrum of bacterial keratitis at a tertiary eye care centre in India.

Authors:  Jayaraman Kaliamurthy; Catti Muniswamy Kalavathy; Pragya Parmar; Christadas Arul Nelson Jesudasan; Philip A Thomas
Journal:  Biomed Res Int       Date:  2013-08-26       Impact factor: 3.411
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.